Demers C - Search Results

1

Effectiveness of comprehensive disease management programmes in improving clinical outcomes in heart failure patients. A meta-analysis.

Roccaforte R, Demers C, Baldassarre F, Teo KK, Yusuf S. Roccaforte R, et al. Among authors: demers c. Eur J Heart Fail. 2005 Dec;7(7):1133-44. doi: 10.1016/j.ejheart.2005.08.005. Epub 2005 Sep 29. Eur J Heart Fail. 2005. PMID: 16198629 Free article.

2

The role of angiotensin II receptor blockers in the treatment of heart failure patients.

Theal M, Demers C, McKelvie RS. Theal M, et al. Among authors: demers c. Congest Heart Fail. 2003 Jan-Feb;9(1):29-34. doi: 10.1111/j.1751-7133.2003.tb00019.x. Congest Heart Fail. 2003. PMID: 12556675 Free article. Review.

3

Growth hormone therapy in heart failure: where are we now?

Demers C, McKelvie RS. Demers C, et al. Congest Heart Fail. 2003 Mar-Apr;9(2):84-90. doi: 10.1111/j.1527-5299.2003.00283.x. Congest Heart Fail. 2003. PMID: 12671339 Free article. Review.

4

Congestive heart failure complicating non-ST segment elevation acute coronary syndrome: incidence, predictors, and clinical outcomes.

Mehta SR, Eikelboom JW, Demers C, Maggioni AP, Commerford PJ, Yusuf S. Mehta SR, et al. Among authors: demers c. Can J Physiol Pharmacol. 2005 Jan;83(1):98-103. doi: 10.1139/y05-003. Can J Physiol Pharmacol. 2005. PMID: 15759056 Clinical Trial.

5

Growth hormone therapy in heart failure: a novel therapy worthy of further consideration?

Demers C, McKelvie RS. Demers C, et al. Expert Opin Investig Drugs. 2005 Aug;14(8):1009-18. doi: 10.1517/13543784.14.8.1009. Expert Opin Investig Drugs. 2005. PMID: 16050793 Review.

6

Impact of candesartan on nonfatal myocardial infarction and cardiovascular death in patients with heart failure.

Demers C, McMurray JJ, Swedberg K, Pfeffer MA, Granger CB, Olofsson B, McKelvie RS, Ostergren J, Michelson EL, Johansson PA, Wang D, Yusuf S; CHARM Investigators. Demers C, et al. JAMA. 2005 Oct 12;294(14):1794-8. doi: 10.1001/jama.294.14.1794. JAMA. 2005. PMID: 16219883 Free article.

7

ACE inhibitors in heart failure: what more do we need to know?

Demers C, Mody A, Teo KK, McKelvie RS. Demers C, et al. Am J Cardiovasc Drugs. 2005;5(6):351-9. doi: 10.2165/00129784-200505060-00002. Am J Cardiovasc Drugs. 2005. PMID: 16259523 Review.

8

Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management.

Arnold JM, Liu P, Demers C, Dorian P, Giannetti N, Haddad H, Heckman GA, Howlett JG, Ignaszewski A, Johnstone DE, Jong P, McKelvie RS, Moe GW, Parker JD, Rao V, Ross HJ, Sequeira EJ, Svendsen AM, Teo K, Tsuyuki RT, White M; Canadian Cardiovascular Society. Arnold JM, et al. Among authors: demers c. Can J Cardiol. 2006 Jan;22(1):23-45. doi: 10.1016/s0828-282x(06)70237-9. Can J Cardiol. 2006. PMID: 16450016 Free PMC article.

9

Plasma matrix metalloproteinase-9 level is correlated with left ventricular volumes and ejection fraction in patients with heart failure.

Yan AT, Yan RT, Spinale FG, Afzal R, Gunasinghe HR, Arnold M, Demers C, McKelvie RS, Liu PP. Yan AT, et al. Among authors: demers c. J Card Fail. 2006 Sep;12(7):514-9. doi: 10.1016/j.cardfail.2006.05.012. J Card Fail. 2006. PMID: 16952784

10

Preferences of patients with heart failure for prognosis communication.

Caldwell PH, Arthur HM, Demers C. Caldwell PH, et al. Among authors: demers c. Can J Cardiol. 2007 Aug;23(10):791-6. doi: 10.1016/s0828-282x(07)70829-2. Can J Cardiol. 2007. PMID: 17703257 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

226 results

Search Page

Filters